Archean Chemical Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.70×0.72×0.72×0.75×0.75×
0.98×1.01×0.95×1.09×0.91×
12.0%13.5%22.6%29.5%39.2%
0.43×0.43×0.47×0.70×0.88×
1.44×1.38×1.28×1.21×1.23×
5.1%5.8%9.4%20.3%28.7%
5.6%5.6%9.1%20.4%45.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACI₹454.40

Archean Chemical Industries Ltd.

· Chemicals
₹ CrorePeersNEOGENAETHERALKYLAMINEBALAMINESTECILCHEMELLENGHCLGNFCMcap ₹5,610 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.750.720.720.70
Interest Burden (Pretax/EBIT) ×0.911.090.951.010.98
EBIT Margin %39.2329.5022.5513.5012.04
Asset Turnover ×0.880.700.470.430.43
Financial Leverage (Assets/Equity) ×1.231.211.281.381.44
ROE (5-step product, year-end total equity) %28.6620.289.405.785.14
ROE (owners' profit / average owners' equity) %45.1820.379.105.555.55
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.